{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,11,14]],"date-time":"2024-11-14T05:25:35Z","timestamp":1731561935970,"version":"3.28.0"},"reference-count":18,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,11,13]]},"DOI":"10.7759\/cureus.73601","type":"journal-article","created":{"date-parts":[[2024,11,13]],"date-time":"2024-11-13T14:46:56Z","timestamp":1731509216000},"source":"Crossref","is-referenced-by-count":0,"title":["Slow-Channel Congenital Myasthenic Syndrome Due to the Novel Variant c.1396G_A in CHRNA1 That Responds Favorably to 3,4-Diaminopyridine: A Case Report"],"prefix":"10.7759","author":[{"given":"Josef","family":"Finsterer","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/B978-0-323-90820-7.00013-6","article-title":"Congenital myasthenic syndromes","volume":"203","author":"Beeson D","year":"2024","unstructured":"Beeson D. Congenital myasthenic syndromes. Handb Clin Neurol. 2024, 203:69-88. 10.1016\/B978-0-323-90820-7.00013-6","journal-title":"Handb Clin Neurol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1186\/s13023-019-1025-5","article-title":"Congenital myasthenic syndromes","volume":"14","author":"Finsterer J","year":"2019","unstructured":"Finsterer J. Congenital myasthenic syndromes. Orphanet J Rare Dis. 2019, 14:57. 10.1186\/s13023-019-1025-5","journal-title":"Orphanet J Rare Dis"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24043730","article-title":"Clinical and pathologic features of congenital myasthenic syndromes caused by 35 genes-a comprehensive review","volume":"24","author":"Ohno K","year":"2023","unstructured":"Ohno K, Ohkawara B, Shen XM, Selcen D, Engel AG. Clinical and pathologic features of congenital myasthenic syndromes caused by 35 genes-a comprehensive review. Int J Mol Sci. 2023, 24:10.3390\/ijms24043730","journal-title":"Int J Mol Sci"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000006126","article-title":"Clinical reasoning: a child with arthrogryposis: congenital myasthenic syndrome-CHRNA1 mutation","volume":"91","author":"Irumudomon O","year":"2018","unstructured":"Irumudomon O, Ghosh PS. Clinical reasoning: a child with arthrogryposis: congenital myasthenic syndrome-CHRNA1 mutation. Neurology. 2018, 91:e995-8. 10.1212\/WNL.0000000000006126","journal-title":"Neurology"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.nmd.2022.12.011","article-title":"A novel phenotype of AChR-deficiency syndrome with predominant facial and distal weakness resulting from the inclusion of an evolutionary alternatively-spliced exon in CHRNA1","volume":"33","author":"Rodr\u00edguez Cruz PM","year":"2023","unstructured":"Rodr\u00edguez Cruz PM, Ravenscroft G, Natera D, et al.. A novel phenotype of AChR-deficiency syndrome with predominant facial and distal weakness resulting from the inclusion of an evolutionary alternatively-spliced exon in CHRNA1. Neuromuscul Disord. 2023, 33:161-8. 10.1016\/j.nmd.2022.12.011","journal-title":"Neuromuscul Disord"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-010-5472-0","article-title":"Identification of previously unreported mutations in CHRNA1, CHRNE and RAPSN genes in three unrelated Italian patients with congenital myasthenic syndromes","volume":"257","author":"Brugnoni R","year":"2010","unstructured":"Brugnoni R, Maggi L, Canioni E, et al.. Identification of previously unreported mutations in CHRNA1, CHRNE and RAPSN genes in three unrelated Italian patients with congenital myasthenic syndromes. J Neurol. 2010, 257:1119-23. 10.1007\/s00415-010-5472-0","journal-title":"J Neurol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1042\/ETLS20180100","article-title":"Targeted therapies for congenital myasthenic syndromes: systematic review and steps towards a treatabolome","volume":"3","author":"Thompson R","year":"2019","unstructured":"Thompson R, Bonne G, Missier P, Lochm\u00fcller H. Targeted therapies for congenital myasthenic syndromes: systematic review and steps towards a treatabolome. Emerg Top Life Sci. 2019, 3:19-37. 10.1042\/ETLS20180100","journal-title":"Emerg Top Life Sci"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.3233\/JND-200566","article-title":"Slow-channel congenital myasthenic syndrome due to a novel mutation in the acetylcholine receptor alpha subunit in a South Asian: a case report","volume":"8","author":"Gooneratne IK","year":"2021","unstructured":"Gooneratne IK, Nandasiri S, Maxwell S, et al.. Slow-channel congenital myasthenic syndrome due to a novel mutation in the acetylcholine receptor alpha subunit in a South Asian: a case report. J Neuromuscul Dis. 2021, 8:163-7. 10.3233\/JND-200566","journal-title":"J Neuromuscul Dis"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.3233\/JND-220798","article-title":"Slow channel syndrome revisited: 40 years clinical follow-up and genetic characterization of two cases","volume":"9","author":"Boon HT","year":"2022","unstructured":"Boon HT, Jacobs B, Wouter VR, et al.. Slow channel syndrome revisited: 40 years clinical follow-up and genetic characterization of two cases. J Neuromuscul Dis. 2022, 9:525-32. 10.3233\/JND-220798","journal-title":"J Neuromuscul Dis"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1002\/mus.27653","article-title":"Pregnancy outcomes in patients with congenital myasthenic syndromes","volume":"66","author":"O'Connell K","year":"2022","unstructured":"O'Connell K, Rooney T, Alabaf S, Ramdas S, Beeson D, Palace J. Pregnancy outcomes in patients with congenital myasthenic syndromes. Muscle Nerve. 2022, 66:345-8. 10.1002\/mus.27653","journal-title":"Muscle Nerve"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-012-6709-x","article-title":"Pregnancy in congenital myasthenic syndrome","volume":"260","author":"Servais L","year":"2013","unstructured":"Servais L, Baudoin H, Zehrouni K, et al.. Pregnancy in congenital myasthenic syndrome. J Neurol. 2013, 260:815-9. 10.1007\/s00415-012-6709-x","journal-title":"J Neurol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/j.jocn.2021.12.016","article-title":"Treatment of slow-channel congenital myasthenic syndrome in a Thai family with fluoxetine","volume":"96","author":"Dejthevaporn C","year":"2022","unstructured":"Dejthevaporn C, Wetchaphanphesat S, Pulkes T, Rattanasiri S, Engel AG, Witoonpanich R. Treatment of slow-channel congenital myasthenic syndrome in a Thai family with fluoxetine. J Clin Neurosci. 2022, 96:85-9. 10.1016\/j.jocn.2021.12.016","journal-title":"J Clin Neurosci"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1093\/braincomms\/fcad299","article-title":"Congenital myasthenic syndromes: a retrospective natural history study of respiratory outcomes in a single centre","volume":"5","author":"Poulos J","year":"2023","unstructured":"Poulos J, Samuels M, Palace J, et al.. Congenital myasthenic syndromes: a retrospective natural history study of respiratory outcomes in a single centre. Brain Commun. 2023, 5:fcad299. 10.1093\/braincomms\/fcad299","journal-title":"Brain Commun"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/j.nmd.2017.08.003","article-title":"Molecular characterization of congenital myasthenic syndromes in Spain","volume":"27","author":"Natera-de Benito D","year":"2017","unstructured":"Natera-de Benito D, T\u00f6pf A, Vilchez JJ, et al.. Molecular characterization of congenital myasthenic syndromes in Spain. Neuromuscul Disord. 2017, 27:1087-98. 10.1016\/j.nmd.2017.08.003","journal-title":"Neuromuscul Disord"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1016\/j.jneuroim.2008.06.026","article-title":"Congenital myasthenic syndromes in childhood: diagnostic and management challenges","volume":"201-202","author":"Kinali M","year":"2008","unstructured":"Kinali M, Beeson D, Pitt MC, et al.. Congenital myasthenic syndromes in childhood: diagnostic and management challenges. J Neuroimmunol. 2008, 201-202:6-12. 10.1016\/j.jneuroim.2008.06.026","journal-title":"J Neuroimmunol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.3389\/fgene.2022.964098","article-title":"Case report: Novel compound heterozygous variants in CHRNA1 gene leading to lethal multiple pterygium syndrome: a case report","volume":"13","author":"Zhuang J","year":"2022","unstructured":"Zhuang J, Wang J, Luo Q, et al.. Case report: Novel compound heterozygous variants in CHRNA1 gene leading to lethal multiple pterygium syndrome: a case report. Front Genet. 2022, 13:964098. 10.3389\/fgene.2022.964098","journal-title":"Front Genet"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1016\/j.ncl.2020.03.004","article-title":"Congenital myasthenic syndromes","volume":"38","author":"Iyadurai SJ","year":"2020","unstructured":"Iyadurai SJ. Congenital myasthenic syndromes. Neurol Clin. 2020, 38:541-52. 10.1016\/j.ncl.2020.03.004","journal-title":"Neurol Clin"},{"key":"ref18","article-title":"Congenital myasthenic syndromes overview","author":"Abicht A","year":"2021","unstructured":"Abicht A, M\u00fcller JS, Lochm\u00fcller H. Congenital myasthenic syndromes overview. Adam MP, Feldman J, Mirzaa GM, et al. (ed): GeneReviews, Seattle, WA; 2021."}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/315737-slow-channel-congenital-myasthenic-syndrome-due-to-the-novel-variant-c1396g_a-in-chrna1-that-responds-favorably-to-34-diaminopyridine-a-case-report","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,13]],"date-time":"2024-11-13T14:46:57Z","timestamp":1731509217000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/315737-slow-channel-congenital-myasthenic-syndrome-due-to-the-novel-variant-c1396g_a-in-chrna1-that-responds-favorably-to-34-diaminopyridine-a-case-report"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,13]]},"references-count":18,"URL":"https:\/\/doi.org\/10.7759\/cureus.73601","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,11,13]]}}}